The continued inclusion of oral corticosteroids (OCS) in treatment guidelines, as well as the accessibility, familiarity, and relatively low cost of this therapeutic option compared with newer alternatives, has contributed to an ongoing overreliance on OCS treatments in severe asthma. This overuse continues despite accumulating evidence to demonstrate the detrimental long-term effects associated with even a short-term, low-dose course of OCS in this patient population.

This webinar will educate you on how the biology of a breast tumour reveals additional information that can support choosing the best treatment plan. It will specifically focus on now-a-days clinical dilemmas, like what is the best treatment for pre-menopausal patients, what is the optimal duration of endocrine therapy and how can I find those nasty tumours. The dilemmas are discussed with the help of cases.

Nebojsa Skrepnik joins Jonathan Sackier on this episode of the EMJ Podcast to discuss opening a clinical research centre and platelet-rich plasma treatments.

This infographic explores a contemporary strategy to decrease the risk of cardiovascular disease and mortality associated with end-stage kidney disease (ESKD).

Infectious disease experts Benoît Guery, Associate Professor of Infectious Diseases, University Hospital, Lausanne, Switzerland, and…

Focusing on the topic of precision medicine in prostate cancer, this podcast offers valuable insights into the impact that its widespread…